BRANCHED COPOLYMER AS PEPTIDE DRUG DELIVERY SYSTEM

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$125,902.00
Award Year:
2006
Program:
SBIR
Phase:
Phase I
Contract:
1R43GM076849-01
Award Id:
80680
Agency Tracking Number:
GM076849
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
EIC LABORATORIES, INC., 111 DOWNEY ST, NORWOOD, MA, 02062
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
FEIWANG
(781) 769-9450
feiwang@eiclabs.com
Business Contact:
RRAUH
(781) 769-9450
DRAUH@EICLABS.COM
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): This SBIR Phase I project will develop a novel branched copolymer as a peptide drug delivery carrier for pharmacological application. The carrier is a highly-structured copolymer that can form micelle-like structures with the peptide drug in aqueous media. The stability of this type of molecular structure will minimize early degradation of the encapsulated peptide drug and decrease harmful side-effects from premature drug release. The polymer/drug micelles will exhibit uniform size and drug loading level, and a predictable, well-controlled drug release rate. The overall objective in the Phase I program is to develop a drug delivery system based on the proposed copolymer for pharmacological applications, especially for delivery of peptide drugs. The specific technical aims are: 1. Synthesis and characterization of the polymer drug carrier. 2. Optimization of the polymer/drug encapsulation process and investigation of the drug release rate. A commercially significant model peptide drug will be used for the encapsulation study. The drug release rate from the polymer/drug formulation will be investigated. 3. Determination of the polymer biocompatibility. The potential cytotoxicity of the synthesized polymer will be investigated using in vitro cytotoxicity assays. Potential markets for protein and peptide drug delivery are highly significant. Many of these drugs have stability problems and undesirable side effects. With this proposed new drug delivery system, more efficient drug delivery with lower dosage is possible. This will reduce untoward side effects and enable efficient drug therapy for disease treatment. New drug delivery systems have had an impact on nearly every branch of medicine. Controlled drug delivery is a $20 billion industry and rising rapidly.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government